Jigar Raythatha

Jigar Raythatha is a venture partner with Third Rock Ventures. Prior to joining Third Rock, he served as president and chief executive officer of Constellation Pharmaceuticals, Inc. from 2017 until its acquisition in 2021. Jigar also led the corporate development function at Constellation from 2009 to 2013. Jigar re-joined Constellation from Jounce Therapeutics Inc., where he held the role of chief business officer from the inception of the company through its IPO. Previously, Jigar worked with Red Abbey Venture Partners, initially, as a Kauffman Fellow and later as a principal and venture partner. Earlier in his career, Jigar held roles of increasing responsibility at Biogen and A.T. Kearney. He earned an MBA from Columbia University and a B.A. in biochemistry and economics from Rutgers University. Jigar is currently chair of the board of directors at Jounce Therapeutics (JNCE) and Triana Biomedicines. He is also a member of the board the American Cancer Society New England Area.